(2022)
Analyzing the human gut mycobiome - A short guide for beginners.
Comput Struct Biotechnol J 20,
608-614.
(Review)
Oliver Kurzai
National Reference Center for Invasive Fungal Infections · Head Fungal Septomics · Head +49 3641 532-1347 oliver.kurzai@leibniz-hki.deCurriculum vitae
Main Research Areas
- Infection biology of human pathogenic fungi (especially Candida albicans)
- Infection biology of Neisseria meningitidis
Professional Career
| Since 2017 | Chair of Medical Microbiology and Mycology, Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg and head of the research group Fungal Septomics at Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena |
| 2009-2016 | Professor (W2) for Fungal Septomics, Friedrich-Schiller-University Jena |
| 2008 | Habilitation in medical microbiology, University Würzburg |
| 2006 | Medical specialist in microbiology, virology and infection epidemiology (Bayerische Landesärztekammer) |
| 2003 | Head of a working group, Institut für Hygiene und Mikrobiologie, University Würzburg |
| 2001-2002 | Doctor in practical training (AiP), Institut für Hygiene und Mikrobiologie, University Würzburg |
| 2002 | Dr. med., “summa cum laude” University Würzburg |
| 2001 | Staatsexamen (state examination) in human medicine, University Würzburg |
Awards · Appointments · Scientific Activities
| Since 2014 | Head of the Nationales Referenzzentrums für invasive Pilzinfektionen (NRZMyk) |
| Since 2013 | Board member of the Integriertes Forschungs- und Behandlungszentrum “Center for Sepsis Control and Care” (CSCC) at the University Hospital Jena |
| Since 2012 | Scientific Manager of the consortium “InfectControl 2020 – New Antiinfection Strategies – Science • Society • Economy” within the BMBF-Programme “Zwanzig 20 – Partnership for Innovation” (Head: Prof. A. Brakhage) |
| Since 2012 | Editor-in-chief, Medical Mycology Case Reports, member (ex officio) of the executive board of the International Society for Human & Animal Mycology (ISHAM) |
| Since 2011 | Elected note taker at the Deutschsprachige Mykologische Gesellschaft DMykG |
| 2015-2016 | Speaker of the ZIK Septomics |
| 2011-2013 | Editor, Journal of Basic Microbiology |
| 2009 | Hans-Rieth-poster prize from the Deutschsprachige Mykologische Gesellschaft (DMykG) |
| 2008 | Award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
| 2003 | Science award from the Unterfränkische Gedenkjahrstiftung |
| 2003 | Dissertation award from the medical faculty of the University Würzburg |
| 2002 | Becton-Dickinson PhD award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
Publications
(2022)
Risk factors for invasive Candida infection in critically ill patients - a systematic review and meta-analysis.
Chest 161(2),
345.
(Review)
(2022)
Molecular profiling reveals characteristic and decisive signatures in patients after allogeneic stem cell transplantation suffering from invasive pulmonary aspergillosis.
J Fungi (Basel) 8(2),
171.
(2021)
Emergence of resistant Candida glabrata in Germany.
JAC Antimicrob Resist 3(3),
dlab122.
(2021)
First case of Kluyveromyces marxianus (Candida kefyr) late onset keratitis after lamellar endothelial corneal graft.
Med Mycol Case Rep 32,
21-24.
(2021)
Aspergillus fumigatus pan-genome analysis identifies genetic variants associated with human infection.
Nat Microbiol 6(12),
1526-1536.
(2021)
[Seroprevalence of COVID-19 and psychosocial effects in the general population: Results of the STAAB-COVID-one program].
Gesundheitswesen 83(12),
965-975.
(2021)
Antifungal activity of nitroxoline against Candida auris isolates.
Clin Microbiol Infect 27(11),
1697.e7.
(2021)
State of Medical Mycology at German Academic Medical Centres: A survey of the German-Speaking Mycological Society (DMYKG) and the Paul-Ehrlich-Society for Chemotherapy (PEG).
Mycoses 64(10),
1177-1182.
(2021)
Noncanonical crRNAs derived from host transcripts enable multiplexable RNA detection by Cas9.
Science 372(6545),
941-948.
